Countries in the developed world have already taken a step forward in the fight against coronavirus. Millions of people in developed countries have been vaccinated. Infections there are declining than ever before. People are starting to return to normal life. Many are busy with summer vacations. The economy is slowly regaining momentum. On the other hand, look at the least developed and developing countries, corona infection is increasing in many countries. Infection levels exceeded. These countries are not getting the necessary vaccines. Even if you get it, you can’t use it. As a result, even the most vulnerable people in the least developed and developing world are being deprived of vaccines.
Such a situation in Corona has pointed the finger at the inequality between the developed and the aspiring world, which may become more apparent in the days to come. The picture of inequality is so severe that while club-restaurants are being launched in Europe and the United States in the wake of the Corona shock, India is witnessing a death march of Covid-19 patients due to lack of oxygen. Brazil is also in a miserable situation. Vaccination is seen as one of the most important steps in the world to deal with corona. However, most of the vaccines have been used in developed countries. Last year, about 192 countries launched a collaborative global initiative called COVAX under the auspices of the World Health Organization to address this inequality in vaccination. The Bill & Melinda Gates Foundation has even provided কোটি 300 million to produce corona vaccines for poor countries in Indian factories. The European Union says the guarantee of vaccination is a global human right.
However, these initiatives are still lagging behind in the way of obtaining vaccines and eliminating inequalities, due to which the infection is increasing in developing countries. In India and South America in particular, the Corona situation has taken a deadly turn. India is one of the most important source of vaccines in normal times. Now the country itself is in a humanitarian crisis. Increased domestic demand for vaccines. Due to this, India has suspended the export of corona vaccine. The global venture Covax is facing a challenge. Because, under this initiative, most of the vaccines are to be supplied from India.
Thousands of people are dying of corona every day in Brazil now. But there is not enough vaccine in the country. By the middle of this year, Brazil had received 1 in 10 of the Oxford-AstraZeneca ticker pledged.
Uncertainty about the second dose
Countries like Bangladesh and Ghana initially started getting vaccinated as per the agreement or promise. Many people in these countries are tickers
Got the first dose. Now that the vaccine supply has stopped, many people in Bangladesh and Ghana are suffering from uncertainty about whether they will get a second dose of vaccine.
Only 2 percent of people in the East African country of Malawi have been vaccinated against coronavirus. Boston Zimba, the country’s physician and immunization expert, said it was a matter of ethics. Developed and rich countries need to think about this (inequality).
Not only the shortage of supplies, but also the existing procedural problems in getting vaccinated and the reluctance of people to get vaccinated is further complicating the crisis. In this regard, the non-government organization CARE said that if one dollar is spent on the production of a dose of corona vaccine, then another 5 dollars is required for the vaccine to be sent from the factory to the concerned country for storage and application. Many countries do not have the necessary infrastructure to protect vaccines. Very little is invested in the salaries, allowances and training of vaccinators. These problems have further complicated the crisis in the country. Countries that do not receive the required vaccines have increased the risk of prolonging the epidemic. As a result, the world economy could lose millions of dollars.
Recently, the United States, India and the European Union have banned the export of corona vaccines or vaccine raw materials. Each country wants to ensure the vaccines it needs first. Such a trend has been identified as ‘vaccine nationalism’. However, the United States has promised to supply 60 million doses of the corona vaccine produced by AstraZeneca to LDCs and developing countries. Sweden wants to vaccinate these countries with 1 million doses of estrogen. However, no specific plan has been released as to when these grant vaccines will be available.
Developed countries, meanwhile, have insisted on ensuring vaccinations for all their citizens to fight the new type of coronavirus. For this, these countries want to increase the production of vaccines. Vaccine manufacturers are also selling additional vaccines in rich and developed countries. Gaining lots. But these institutions are not very keen to share the dividends of corporate income with the poor.
In the first quarter of 2021 (January-March), US pharmaceutical company Pfizer sold ট 3.5 billion worth of vaccines. However, the company has promised to supply less than 2 percent of the vaccine produced this year to the least developed and developing countries. Another US pharmaceutical company, Moderna, expects to sell ড 1.8 billion worth of coronavirus vaccines by the end of the year. The company agreed to deliver the vaccine to Covax this week.
Oxford – Corona ticker file invented by AstraZeneca.
Oxford – Corona ticker file invented by AstraZeneca. Photo: Reuters
In addition to vaccination nationalism and the tendency not to share corporate dividends, intellectual property has emerged as a major problem in the case of corona vaccines. US President Joe Biden wants to vaccinate poor countries. But his administration is reluctant to give these countries the right to vaccinate for local production. Experts say that countries that have the capacity to acquire intellectual property could produce the corona vaccine themselves. This increased the production of ticks. It would have been easier to pull the reins of the epidemic quickly.
It is also believed that if vaccines were produced locally, people would be more interested in getting vaccinated. Many would be scared of the quality of vaccines produced abroad. In this regard, the President of the Democratic Republic of Congo, Felix Tishishekedi, said that it would increase people’s confidence and self-confidence. Because, they understood that we have produced this vaccine for us.
Lack of supply of covacs
Jane Rizvi, a pharmacologist at Public Citizen, a Washington-based advocacy group, warned that Kovacs would have to pay a price if it relied on vaccines from India. Covacs had promised to supply 235 million doses of corona vaccine by April. 325 million dose vaccines are expected to be delivered by May. At the end of the year, Kovacs is expected to deliver a total of 200 crore doses of vaccine to the least developed and developing countries.
If the situation in India does not return to normal soon, priority will be given to vaccination within the country. No other country will be vaccinated right now.
Aadar Punewala, Head of Seram Institute of India.
But to fulfill the promise perfectly
Couldn’t. Jane Rizvi said Covax was able to deliver one-third of the promised vaccine at the end of March. As of last Tuesday, a total of 52.4 million doses of corona vaccine had been delivered, which is less than a quarter of the supply target by April. In this situation, the global vaccine alliance Gavi says, now the second dose of corona vaccine is being given priority. At the same time, rich countries have been urged to give surplus vaccines to poor countries.
On the one hand, the poorer countries are suffering from a severe coronary heart disease. Many people in Bangladesh, Ghana and other countries are skeptical about getting the second dose of vaccine on time. On the other hand, many rich countries have a surplus of vaccines. Stocked ticks may expire if not used in time. Can be ruined. Even a few poor countries, despite having adequate stocks, could not vaccinate as targeted. These vaccines are also at risk of expiration.
According to CARE, the crisis over vaccination in African countries is quite intense. About two dozen countries on this relatively poor continent failed to meet the target. Two months ago, the Democratic Republic of the Congo received 1.6 million doses of the corona vaccine invented by AstraZeneca. Corona vaccination began in the country in April. However, less than two thousand people have been vaccinated in the country. For this reason, the country may have to give unused vaccines to its neighbors before the expiration date.
The situation is much the same in Ivory Coast. By the end of February, the country had received 544,000 doses of the corona vaccine invented by Kovax. About 155,000 doses of the vaccine have been used in the country so far. The people of the country are less interested in getting the corona vaccine.
Experts say many people in Africa are afraid of the side effects of the vaccine. Governments have not campaigned enough to allay these fears. Or the campaign started much later. So people are not getting vaccinated.
On the one hand, rich countries have surplus stocks of vaccines, on the other hand, many poor countries are not able to use the vaccines on time. Again, many least developed and developing countries are not getting adequate vaccinations despite the demand. In such a turbulent situation, Corona’s highly contagious Indian type has raised concerns.
On the world
Adar Punewala, head of the Seram Institute of India, India’s largest vaccine manufacturer, said that if the situation in India does not return to normal soon, priority will be given to vaccination within the country. No other country will be vaccinated right now.
l Translation: Anindya Saimum